TARGET Cancers Selected for Study
Below is the list of cancers selected for study by NCI’s Therapeutically Applicable Research to Generate Effective Treatments (TARGET) program. For each cancer type, TARGET researchers have published an overview of the characterizations performed and multiple types of analyses of the data. For some diseases, data collection and analysis occurred in separate phases.
Supplemental and associated data files for these studies can be found on the publication pages at the GDC.
Cancer Type Studied |
# Cases Characterized |
Publication |
---|---|---|
Acute Lymphoblastic Leukemia | 1,802 |
|
Acute Myeloid Leukemia | 2,145 | |
Wilms | 652 | |
Clear Cell Sarcoma | 13 | |
Rhabdoid Tumor | 69 | |
Neuroblastoma | 1,132 | |
Osteosarcoma | 383 | |
Meta-Analysis Studies | ||
Pan-Cancer Model Systems |